iBio
IBIO
#10296
Rank
S$66.42 M
Marketcap
S$0.94
Share price
-4.00%
Change (1 day)
-33.98%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): S-$0.99

According to iBio's latest financial reports the company's current EPS (TTM) is S-$0.97. In 2025 the company made an earnings per share (EPS) of S-$2.25 an increase over its 2024 EPS that were of S-$8.38.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.99-55.98%
2025S-$2.25-73.08%
2024S-$8.38-93.88%
2023S-$136.83-8.14%
2022S-$148.9692.67%
2021S-$77.31-80.33%
2020S-$393.00-35.11%
2019S-$605.61-38.96%
2018S-$992.18-6.1%
2017S-$1,05736.67%
2016S-$773.1233.33%
2015S-$579.8450%
2014S-$386.56-53.85%
2013S-$837.55-7.14%
2012S-$901.98-64.1%
2011S-$2,51377.27%
2010S-$1,417144.44%
2009S-$579.8412.93%
2008S-$513.4612.2%
2007S-$457.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.61-990.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
S-$0.67-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S-$8.63 793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$6.49 572.00%๐Ÿ‡บ๐Ÿ‡ธ USA